214 related articles for article (PubMed ID: 23852767)
1. Evolving of therapeutic strategies for CNS-PNET.
Massimino M; Gandola L; Biassoni V; Spreafico F; Schiavello E; Poggi G; Pecori E; Vajna De Pava M; Modena P; Antonelli M; Giangaspero F
Pediatr Blood Cancer; 2013 Dec; 60(12):2031-5. PubMed ID: 23852767
[TBL] [Abstract][Full Text] [Related]
2. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
[TBL] [Abstract][Full Text] [Related]
3. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
4. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
5. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
6. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Ottensmeier H; Deinlein F; Benesch M; Kwiecien R; Pietsch T; Warmuth-Metz M; Faldum A; Kuehl J; Kortmann RD; Rutkowski S
Neuro Oncol; 2013 Feb; 15(2):224-34. PubMed ID: 23223339
[TBL] [Abstract][Full Text] [Related]
7. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
8. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
[TBL] [Abstract][Full Text] [Related]
9. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Zacharoulis S; Levy A; Chi SN; Gardner S; Rosenblum M; Miller DC; Dunkel I; Diez B; Sposto R; Ji L; Asgharzadeh S; Hukin J; Belasco J; Dubowy R; Kellie S; Termuhlen A; Finlay J
Pediatr Blood Cancer; 2007 Jul; 49(1):34-40. PubMed ID: 16874765
[TBL] [Abstract][Full Text] [Related]
10. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Kushner BH; Meyers PA
J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
[TBL] [Abstract][Full Text] [Related]
11. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
13. Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
Gerber NU; von Hoff K; Resch A; Ottensmeier H; Kwiecien R; Faldum A; Matuschek C; Hornung D; Bremer M; Benesch M; Pietsch T; Warmuth-Metz M; Kuehl J; Rutkowski S; Kortmann RD
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):863-71. PubMed ID: 24969797
[TBL] [Abstract][Full Text] [Related]
14. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.
Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S
J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122
[TBL] [Abstract][Full Text] [Related]
15. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
Chintagumpala M; Hassall T; Palmer S; Ashley D; Wallace D; Kasow K; Merchant TE; Krasin MJ; Dauser R; Boop F; Krance R; Woo S; Cheuk R; Lau C; Gilbertson R; Gajjar A
Neuro Oncol; 2009 Feb; 11(1):33-40. PubMed ID: 18796696
[TBL] [Abstract][Full Text] [Related]
17. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
[TBL] [Abstract][Full Text] [Related]
18. Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour.
Szychot E; Seunarine K; Mankad K; Thust S; Clark C; Gaze MN; Michalski A
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28509337
[TBL] [Abstract][Full Text] [Related]
19. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]